Senseonics Holdings DIO Ratio 2011-2026 | SENS

Annual DIO Ratio Senseonics Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
104	110	152	182	146	86.4	152	138	112	264	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
264	86.4	145

Quarterly DIO Ratio Senseonics Holdings

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
140	109	119	85.8	-	57.2	152	162	-	175	214	190	-	171	227	314	-	159	243	233	-	-	343	51.5	-	202	169	184	-	121	243	182	-	92.3	159	151	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
343	51.5	172

DIO Ratio of other stocks in the Diagnostics research industry

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	156	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	25.4	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	137	-	-	$ 1.31 B	USA
DermTech DMTK	33.5	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	9.34	$ 203.06	-	$ 22.5 B	USA
Co-Diagnostics CODX	1.69 K	$ 4.29	-	$ 5.71 M	USA
Castle Biosciences CSTL	47.2	$ 20.7	-	$ 600 M	USA
Aspira Women's Health AWH	32.2	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Fulgent Genetics FLGT	7.17	$ 18.68	-0.53 %	$ 575 M	USA
Biocept BIOC	21.9	-	-13.05 %	$ 7.29 M	USA
Oxford Immunotec Global PLC OXFD	210	-	-	$ 562 M	Britain
Guardant Health GH	82.1	$ 131.62	-	$ 16.5 B	USA
CareDx, Inc CDNA	48.3	$ 22.97	-	$ 1.22 B	USA
Chembio Diagnostics CEMI	97.6	-	0.22 %	$ 16.8 M	USA
ICON Public Limited Company ICLR	0.213	$ 146.18	-	$ 11.5 B	Irlanda
Interpace Biosciences IDXG	29.1	$ 1.6	-3.03 %	$ 7.08 M	USA
Illumina ILMN	138	$ 160.97	-	$ 25 B	USA
HTG Molecular Diagnostics HTGM	116	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	89.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	131	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	42.1	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	62.8	-	0.12 %	$ 80.1 M	China
Lantheus Holdings LNTH	40.4	$ 104.52	-	$ 7.05 B	USA
Charles River Laboratories International CRL	35.3	$ 187.51	-	$ 9.29 B	USA
Exact Sciences Corporation EXAS	60.9	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	79	$ 1 131.49	-	$ 23.3 B	Schweiz
NeoGenomics NEO	24.4	$ 11.15	-	$ 1.43 B	USA
Myriad Genetics MYGN	42.8	$ 4.33	-	$ 401 M	USA
Natera NTRA	25.8	$ 212.07	-	$ 29 B	USA
Pacific Biosciences of California PACB	173	$ 1.31	-	$ 393 M	USA
Personalis PSNL	12.1	$ 9.59	-	$ 856 M	USA
Koninklijke Philips N.V. PHG	89	$ 26.46	-	$ 25.1 B	Niderland
QIAGEN N.V. QGEN	141	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	1.02 K	-	-	$ 2.69 B	USA
Biomerica BMRA	147	$ 2.05	-	$ 4.71 M	USA
Laboratory Corporation of America Holdings LH	18.9	$ 266.16	-	$ 22.1 B	USA
Twist Bioscience Corporation TWST	51.5	$ 76.17	-	$ 4.56 B	USA
Thermo Fisher Scientific TMO	86.5	$ 469.34	0.1 %	$ 177 B	USA
Trinity Biotech plc TRIB	212	$ 0.65	-	$ 233 M	Irlanda
Motus GI Holdings MOTS	3.37 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	147	$ 9.1	-1.57 %	$ 1.97 B	USA
Invitae Corporation NVTA	126	-	-	$ 21.2 M	USA